Affordable Access

deepdyve-link
Publisher Website

The clinical value of the prostatic exosomal protein expression in the diagnosis of chronic prostatitis: a single-center study.

Authors
  • Feng, Xingliang1
  • Zhang, Meng1, 2
  • Zhang, Ligang1
  • Hu, Huaqing3
  • Zhang, Li1
  • Zhang, Xiansheng1
  • Fan, Song4
  • Liang, Chaozhao5
  • 1 Department of Urology, The First Affiliated Hospital of Anhui Medical University and Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Jixi Road, Shushan District, Hefei, Anhui, 230022, People's Republic of China. , (China)
  • 2 Urology Institute of Shenzhen University, The Third Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, People's Republic of China. , (China)
  • 3 Department of Health Examination Center, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, 230022, PR China. , (China)
  • 4 Department of Urology, The First Affiliated Hospital of Anhui Medical University and Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Jixi Road, Shushan District, Hefei, Anhui, 230022, People's Republic of China. [email protected] , (China)
  • 5 Department of Urology, The First Affiliated Hospital of Anhui Medical University and Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Jixi Road, Shushan District, Hefei, Anhui, 230022, People's Republic of China. [email protected] , (China)
Type
Published Article
Journal
International Urology and Nephrology
Publisher
Springer-Verlag
Publication Date
Feb 01, 2020
Volume
52
Issue
2
Pages
225–232
Identifiers
DOI: 10.1007/s11255-019-02313-z
PMID: 31720952
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Levels of urinary prostatic exosomal protein (PSEP) were detected to evaluate the clinical potential of PSEP as a diagnostic marker of chronic prostatitis (CP). The level of urinary PSEP was measured in 412 cases by an enzyme-linked immunosorbent assay kit, including 202 controls and 210 CP cases. Of the CP patients, 116 cases met the definition of the USA National Institutes of Health category III (NIH-III), with 60 cases of NIH-IIIA and 56 cases of NIH-IIIB. The ages, body mass indexes (BMI), white blood cell (WBC) levels in expressed prostatic secretions (EPS), lecithin body counts in EPS, urine PSEP levels both before and after prostate massage obtained from the CP patients and NIH-CPSI scores were analyzed. In the diagnosis of CP, the PSEP contents in the urine samples before and after prostate massage manifested a sensitivity of 86.93% vs. 61.06%, and a total coincidence rate of 85.24% vs. 61.06%, respectively. The area under the ROC curve was 0.926 vs. 0.709 for the before and after massage PSEP contents, respectively. Besides, during the follow-up of patients with CP, the improvement in symptoms was not correlated with the level changes of PSEP. Measurement of PSEP levels for the clinical diagnosis of CP is objective and painless. It could be a novel, simple, and noninvasive method for the diagnosis of CP. However, differences in fluid intake may result in a concentration or dilution of urine, which would ultimately affect the judgment of PSEP results.

Report this publication

Statistics

Seen <100 times